antibiotic steward | ID PharmD at Providence St Johns | Philly ➡️ Los Angeles | #shorterisbetter 💊
Joined October 2017
- Tweets 1,555
- Following 365
- Followers 631
- Likes 5,528
154 Photos and videos
Chris Cho retweeted
21 Aug 2024
Efficacy for prolonged infusion beta-lactam dosing schemes has been previously described, but there has been less focus on the safety of this strategy!
🆕️🔥 #IJAA
Meta-analysis on safety of standard vs prolonged infusion of beta-lactams #IDXposts
sciencedirect.com/science/ar…
2
31
75
13,516
Chris Cho retweeted
Check out our ASP Team’s latest newsletter!
💊🦠🆔 #idccm #IDCCM #ASP #AntimicrobialStewardship #IDforMe
3
5
477
Chris Cho retweeted
1 Jul 2024
New insights into the therapeutic management of Varicella-Zoster Virus meningitis: a series of 123 PCR-confirmed cases
✅ Just Accepted
🔗 bit.ly/4bkqu6V
12
16
2,360
Chris Cho retweeted
1 Jul 2024
Yahoo!! Another article to support PO stepdown for Streptococcal bacteremias. Stoked to be a part of this excellent team!
academic.oup.com/ofid/articl…
3
11
91
7,278
Chris Cho retweeted
28 May 2024
Things We Do for No Reason™: S. pneumoniae and Legionella urine antigen testing
The authors suggest we should never order a S.pneumoniae UAT
For legionella UAT, it could be considered in severe CAP with risk factors or appropriate clinical syndrome
doi.org/10.1002/jhm.13418
4
55
199
26,376
Chris Cho retweeted
12 Jan 2024
‼️Did you know that susceptibilities for many PO cephalosporins are inferred from cefazolin, not ceftriaxone? May overcall resistance but safest option if unable to test directly.
Removed cefdinir from our adult formulary and switched to cefuroxime. Here’s why! #downwithcefdinir
4
28
112
10,104
Chris Cho retweeted
28 May 2024
#IDtwitter
Anyone have experience with using pivmecillinam?
Surprised to read that it frequently maintains activity amongst esbl and CRE isolates.
Recently approved by US FDA.
Is there a catch?
doi.org/10.1093/ofid/ofae296
15
6
50
12,588
Chris Cho retweeted
14 May 2024
🆕️🔥Systemic review and meta-analysis
Ceftazidime-avibactam combination therapy versus monotherapy for treating carbapenem-resistant gram-negative infections #IDXposts
link.springer.com/article/10…
44
117
13,371
Chris Cho retweeted
13 May 2024
🔥ORACLE🔥 @yourICM
@TrubianoJason
A Pilot RCT of Direct Oral Challenge(DOC) vs Routine Care in Low-Risk Penicillin Allergy in Critical Illnes
This study supports the safety & efficacy of DOC in low-risk[PEN -FAST< 3] penicillin allergy in ICU #IDXposts
link.springer.com/article/10…
1
27
71
11,232
Chris Cho retweeted
🆕️⚡️⚡️#JAC
Clinical outcomes in patients with pip/tazo-non-susceptible but ceftriaxone-susceptible E. coli or K. pneumoniae bloodstream infection
B/w What's the mechanism of resistance for such phenotype? #IDXposts
academic.oup.com/jac/article…
5
21
109
23,826
Chris Cho retweeted
🆕️🔥Systematic Review & Meta-analysis
6 retros N:1746
Short Vs. Prolonged Duration of Therapy for Pseudomonas aeruginosa Bacteremia
No sig # in 30d mortality
Ongoing RCTs 7d Vs 14d:
SHORTEN-2
OPTIMISE
BALANCE
H/t @shorten2trial #IDXposts @BradSpellberg
journalofhospitalinfection.c…
5
41
152
35,543
Chris Cho retweeted
9 May 2024
In a retrospective study, there was no difference in outcomes including 30 day mortality between linezolid and clindamycin in GAS infections. #MADID2024 @MAD_ID_ASP @SIDPharm @BaileyGarnerRx
14
53
4,258
Chris Cho retweeted
9 May 2024
Dr. Thomas Lodise on the efficacy and safety of #cefiderocol in treating critically ill patients with carbapenem-resistant gram-negative bacterial infections. contagionlive.com/view/fetro…
2
2
405
Chris Cho retweeted
29 Apr 2024
Combination of anti-staphylococcal β lactam with standard therapy compared to standard therapy alone for the treatment of MRSA bacteraemia: a post hoc analysis of the CAMERA2 trial using a desirability of outcome ranking (DOOR) approach
✅ Just Accepted
bit.ly/3QkiZFy
25
44
6,215
Chris Cho retweeted
28 Apr 2024
Another nail in the vancomycin coffin. After accounting for laboratory testing, pharmacist management time, and costs associated with vancomycin associated AKI, daptomycin saved $166 per patient when used in place of vancomycin. academic.oup.com/ofid/advanc…
3
16
85
8,704
Chris Cho retweeted
28 Apr 2024
Sneak peak of 🆕️🔥 @IDSAInfo/ @ESCMID SAB guidelines
🔆Risk stratification,high or low instead of complicated/uncomplicated
🔆Patients with high-risk features at baseline but TTE & PET/CT are negative, short course 14d
Slides shared @seanongwx
#ESCMIDGLOBAL2024
Oral Abx?!
2
33
108
17,904
Chris Cho retweeted
ICYMI 🔥 FDA approved an updated label with additional data reinforcing the safety & efficacy profile of Biktarvy® to treat pregnant people with HIV-1 (PWH) with suppressed viral loads🔥
#IDXposts
gilead.com/news-and-press/pr…
3
27
71
17,260